...Good morning. I'm Sean Power, Chief Financial Officer and Corporate Secretary of TG Therapeutics and will be presiding over today's Virtual Meeting of Stockholders. On behalf of our company (technical difficulty) for a 2024 Annual Shareholders Meeting, which is now officially called to order. We're very pleased to have each of you in attendance at today's virtual meeting. Let me begin by introducing the Directors of the company in attendance. With us today are Michael Weiss, Laurence Charney, Yann Echelard, Kenneth Hoberman, Daniel Hume, and Dr. Sagar Lonial. Also virtually present here today is Richard Bird of KPMG LLP, our Independent Auditors for the year ending December (technical difficulty) and Matthew Mamak of Alston & Bird LLP, our Legal Counsel, who will serve as Secretary and the Inspector of Elections of the meeting. Our order of business this morning will be to introduce an (technical difficulty) described in the proxy statement for this 2024 Annual Meeting of Stockholders,...
